Zobrazeno 1 - 6
of 6
pro vyhledávání: '"J. M. Aramendía"'
Autor:
José Esteban Salgado, J. M. Aramendía, O. A. Fernández-Hidalgo, E. Lozano, J. Rebollo, R. Martínez-Monge, M. L. Subirá, A. Brugarolas
Publikováno v:
Revista de Medicina de la Universidad de Navarra. :5-13
Propósito: Estudio fase 11 con quimioterapia intensiva y soporte con células progenitoras autólogas obtenidas de la sangre en pacientes con cáncer de mama metastásico. Métodos: Tratamos 49 pacientes con una pauta de dos agentes citotóxicos a d
Autor:
M J, García Velloso, J F, Boán García, L M, Villar Luque, J M, Aramendía Beitia, G, López García, J A, Richter Echeverría
Publikováno v:
Revista espanola de medicina nuclear. 22(4)
The aim of this study was to evaluate the clinical utility of FDG-PET for detecting recurrent disease in patients with ovarian cancer.Twenty-one FDG-PET studies performed in 19 patients who had previously undergone surgery and chemotherapy for ovaria
Autor:
J E, Salgado, J M, Aramendía, O A, Fernández-Hidalgo, E, Lozano, J, Rebollo, R, Martínez-Monge, M L, Subirá, A, Brugarolas
Publikováno v:
Revista de medicina de la Universidad de Navarra. 41(3)
Phase II study with intensive chemotherapy and autologous stem cells support in patients with metastatic breast cancer.Forty-nine patients were treated with high-doses of two cytotoxic drugs and support with stem cells obtained from several leukapher
Publikováno v:
Revista de medicina de la Universidad de Navarra. 40(3)
The results of two sequential trials, the first one with high dose interleukin 2 (IL2) by continuous intravenous infusion and the second one with subcutaneous IL2 and alpha-interferon (alpha IFN), performed in consecutive patients with metastatic mel
Autor:
G, Alonso Curbera, R, González-Manzano, J M, Aramendía Beitia, R, Martínez Monge, L, Agüera Fernández, J, Rebollo Liceaga
Publikováno v:
Revista de medicina de la Universidad de Navarra. 38(1)
Thirty previously untreated patients with advanced germ cell testicular tumours received PVB or BEP. Four patients with bulky disease underwent debulking surgery before initiating chemotherapy and two between cycles of treatment. Twenty-seven (90%) c
Publikováno v:
Scopus-Elsevier
se presentan los resultados de dos estudios secuenciales, el primero con dosis altas de interleuquina-2 en infusión intravenosa continua y el segundo con IL2 subcutánea e interferón alfa (IFN alfa), en pacientes con melanoma y carcinoma renal meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f5dcd078894985a8048f5b6ce9de3de
http://www.scopus.com/inward/record.url?eid=2-s2.0-0030177438&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0030177438&partnerID=MN8TOARS